| Study | Reason for exclusion |
|---|---|
| Bart 2010 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Beauchaine 2003 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Becker 2011 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Beery 1994 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Benamor 2014 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Biederman 1999 | Not possible to obtain the disaggregated data for the methylphenidate group |
| Biederman 2009 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Bohane 2010 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Brossard‐Racine 2012 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Byrne 1998 | No data on adverse events |
| Casat 1995 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Cavadas 2007 | No data on adverse events |
| Chambers 2012 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Chavez 1999 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Chelonis 2010 | Lack of relevant outcome measures |
| Chelonis 2011 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Clarke 2003 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Conzelmann 2014 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Cooper 2011 | Unable to obtain the disaggregated data on children receiving methylphenidate, either from the publication or through personal email correspondence with the study authors |
| De Zeeuw 2012 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| DeVito 2009 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Drtílková 1990 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Epstein 2010 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Faraone 2007b | No data on adverse events |
| Fegert 2006 | No data on adverse events |
| Foodman 1996 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Frank 1993 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Funk 1993 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Gau 2009 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Gimpel 2005 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Glenngård 2013 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Gormez 2012 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Gould 2009 | No ADHD diagnosis |
| Gualtieri 1985 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Guimarães 2009 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Gurkan 2011 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Hautmann 2013 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Hawcutt 2012 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Hawk 2003 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Heiser 2004 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Hidas 2011 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Hood 2005 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Hoza 1992 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Hwang 2012 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Jonkman 1999 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Kerdar 2007 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Kereszturi 2008 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Keulers 2007 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Klein 2002 | No relevant outcomes (experimental, neurocognitive or functional). No data on adverse events |
| Kramer 2001 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Lajoie 2005 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Lawrence 2005 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Matier 1992 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Mayes 1993 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Miller 1994 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Miller 1996 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Miranda 2006 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Monden 2012a | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Monden 2012b | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Nahshoni 2012 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Neef 2005 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Negrao 2011 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Nigg 1996 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Nikles 2005 | No relevant outcome measures (experimental, neurocognitive or functional). The paper investigates the patients' satisfaction with N‐of‐1 trials |
| Nolan 1999 | Unable to obtain the disaggregated data for the methylphenidate group |
| Ohashi 2010 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Orgill 1996 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Overcash 2005 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Ozdag 2004 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Palomino 2012 | Unable to obtain the disaggregated data for the methylphenidate group |
| Park 2012 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Pelham 1986 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Pelham 2011 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Perera 2012 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Pierce 2008 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Poulton 2013 | Unable to obtain the disaggregated data for the methylphenidate group |
| Prehn‐Kristensen 2011 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Rapport 1985 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Rhodes 2004 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Rhodes 2006 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Roman 2002 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Rubia 2009 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Rubia 2009a | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Rubio 2011 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Schecklmann 2011 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Scheres 2003 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Scheres 2006 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Schmiedeler 2009 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Shafritz 2004 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Shaywitz 1982 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Sheppard 1999 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Snyder 2008 | Unable to obtain the disaggregated data for the methylphenidate group |
| Solanto 1989 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Spivak 2001 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Stein 1999 | Unable to obtain the disaggregated data for the methylphenidate group |
| Syrigou‐Papavasiliou 1988 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Tabori‐Kraft 2007 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Tamm 2007 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Tillery 1998 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Trenque 2009 | Unable to obtain the disaggregated data for the methylphenidate group |
| Van der Meere 2009 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Van der Oord 2012 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Vance 1999 | Unable to obtain the disaggregated data for the methylphenidate group |
| Vickers 2002 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Vogt 2011 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Winterstein 2007 | Unable to obtain the disaggregated data for the methylphenidate group |
| Winterstein 2012 | Unable to obtain the disaggregated data for the methylphenidate group |
| Wong 2012 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Yeh 2012 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Zachor 2006 | Unable to obtain the disaggregated data for the methylphenidate group |
| Zalsman 2003 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
| Zang 2005 | No relevant outcome (experimental, neurocognitive or functional). No data on adverse events |
ADHD: attention deficit hyperactivity disorder.